The “Angelina Effect” – Genetic Testing Becomes a Global Phenomenon

Angelina Jolie’s actions to undergo a double mastectomy after genetic testing revealed her predisposition to cancer has created an “Angelina Effect” – a growing demand for attaining personal genetic data. In Part Four of our exclusive series with ANZIIF: ‘How Advances in Medical Technology Are Impacting Insurance’, Karen Jones (Partner) and Dominic Flannery (Special Counsel) […]

Wearables and Health Tracking – An Insurer’s Dream or Nightmare?

Wearables such as FitBits are turning our bodies into real-time health data sources. In Part Three of our exclusive series with ANZIIF: ‘How Advances in Medical Technology Are Impacting Insurance’, Karen Jones (Partner) and Dominic Flannery (Special Counsel) provide commentary on the impending impact of this technology on the insurance landscape. Wouldn’t it be incredible […]

Discretionary timing of bank’s ‘target hardening’ technology deemed sound in Court of Appeal decision

Banks and other institutions invest significant amounts of time and capital in building systems, processes and procedures to plan for untoward criminal activity to ensure their staff, customers and the public are safe. Wotton + Kearney has recently represented Westpac in a matter in the ACT Court of Appeal Roberts v Westpac Corporation [2016] ACTA […]

Advances in medical technology – an insurer’s best friend?

With technological advances in the medical industry outpacing those in the insurance industry, Wotton + Kearney Partner, Karen Jones and Dominic Flannery (Special Counsel) advise insurers to be alert to the opportunities created through the use of these advancements in the defence of proceedings. The pace of medical advancements in the last decade has revolutionised […]